Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianyang Hu

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Scientific Reports|November 4, 2015
Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In VivoZhenjian Zhuo, Jianyang Hu, Xiaolin Yang, et al.
Biochemical Pharmacology|May 6, 2021
Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancerHaiyan Sun, Tong Ou, Jianyang Hu, et al.
The Journal of Biological Chemistry|May 29, 2020
Phase-separated condensate-aided enrichment of biomolecular interactions for high-throughput drug screening in test tubesMin Zhou, Weiping Li, Jian Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 16, 2025
Fangchinoline suppresses melanoma metastasis by inducing senescence of circulating tumor cellsJunhao Chen, Jianyang Hu, Jiapeng He, et al.
Biochemical Pharmacology|October 28, 2017
The cycloartane triterpenoid ADCX impairs autophagic degradation through Akt overactivation and promotes apoptotic cell death in multidrug-resistant HepG2/ADM cellsHaiyan Sun, Maohua Huang, Nan Yao, et al.
Journal of Clinical and Experimental Hepatology|December 2, 2025
Prediction and Validation of Severe Early Allograft Dysfunction Following Pediatric Living Donor Liver TransplantationWeiming He, Xiaoke Dai, Jianyang Hu, et al.
Pharmacological Research|December 28, 2022
Corrigendum to "Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin" Pharmacol. Res. Vol. 123 (2017) 130-142Liping Chen, Weiqian Mai, Minfeng Chen, et al.
Epigenetics & Chromatin|November 10, 2024
FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancerQingling He, Jianyang Hu, Hao Huang, et al.
American Journal of Cancer Research|May 18, 2016
In vitro and in vivo antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathwaysXueping Lei, Minfeng Chen, Qiulin Nie, et al.
Journal of Hematology & Oncology|January 16, 2026
CBX3 confers ferroptosis resistance during blood-borne metastasisChun Wu, Xuefei Liu, Boxi Zhao, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Scientific Reports|November 4, 2015
Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In VivoZhenjian Zhuo, Jianyang Hu, Xiaolin Yang, et al.
Biochemical Pharmacology|May 6, 2021
Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancerHaiyan Sun, Tong Ou, Jianyang Hu, et al.
The Journal of Biological Chemistry|May 29, 2020
Phase-separated condensate-aided enrichment of biomolecular interactions for high-throughput drug screening in test tubesMin Zhou, Weiping Li, Jian Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 16, 2025
Fangchinoline suppresses melanoma metastasis by inducing senescence of circulating tumor cellsJunhao Chen, Jianyang Hu, Jiapeng He, et al.
Biochemical Pharmacology|October 28, 2017
The cycloartane triterpenoid ADCX impairs autophagic degradation through Akt overactivation and promotes apoptotic cell death in multidrug-resistant HepG2/ADM cellsHaiyan Sun, Maohua Huang, Nan Yao, et al.
Journal of Clinical and Experimental Hepatology|December 2, 2025
Prediction and Validation of Severe Early Allograft Dysfunction Following Pediatric Living Donor Liver TransplantationWeiming He, Xiaoke Dai, Jianyang Hu, et al.
Pharmacological Research|December 28, 2022
Corrigendum to "Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin" Pharmacol. Res. Vol. 123 (2017) 130-142Liping Chen, Weiqian Mai, Minfeng Chen, et al.
Epigenetics & Chromatin|November 10, 2024
FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancerQingling He, Jianyang Hu, Hao Huang, et al.
American Journal of Cancer Research|May 18, 2016
In vitro and in vivo antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathwaysXueping Lei, Minfeng Chen, Qiulin Nie, et al.
Journal of Hematology & Oncology|January 16, 2026
CBX3 confers ferroptosis resistance during blood-borne metastasisChun Wu, Xuefei Liu, Boxi Zhao, et al.
Pageof 5